Project Number 1RF1AG077627-01 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Nerve growth factor (NGF) metabolic dysfunction as a marker of cognitive decline in autosomal dominant Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 8. Novel Analyses, Methodologies and Techniques for Biomarker Discovery and Validation Researcher and Organization Principal Investigator QUIROZ, YAKEEL T. Principal Investigator First Name YAKEEL T. Principal Investigator Last Name QUIROZ Awardee Organization MASSACHUSETTS GENERAL HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-19-070: Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) FY Overall Cost $1,969,396 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official ROVESCALLI, ALESSANDRA C
